Dr. Jonathan A. Gerber, MD

Dr. Gerber practices at John Sealy Hospital in Galveston, Texas, part of The University of Texas System.

Dr. Gerber's NPI, 1063857571, was assigned on May 10, 2013. Dr. Gerber graduated from McGovern Medical School in 2013. Dr. Gerber holds Texas license R6009.

Dr. Gerber's primary practice is John Sealy Hospital, at 301 University Boulevard, Galveston, TX 77555 in Galveston County. The practice phone is (409) 772-1011.

Dr. Gerber's primary practice is John Sealy Hospital in Galveston, Texas, part of The University of Texas System. The medical group on file is UTMB Faculty Group Practice. Dmand AI also links Dr. Gerber to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gerber practices, 2 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Gerber's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Gerber is board certified in pediatric urology by the American Board of Urology. Dmand AI has Dr. Gerber's licenses on file in 2 states: Texas and Pennsylvania.

Dmand AI lists kidney removal surgery among the conditions Dr. Gerber treats.

CMS data shows 12 Medicare services from Dr. Gerber across 1 procedure code in 2024, for 17 Medicare patients. Medicare paid $1,250 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 17 Medicare patients who saw Dr. Gerber in 2024. The largest group is under 65, with 0 patients. 75% of them have high blood pressure. Their average risk score is 1.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gerber's median patient age at 11, with 17% women.

In 2018, Dr. Gerber wrote 21 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $288 in total drug cost. In 2017, CMS named 52 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Gerber for performance year 2024, reported as part of a group. Dr. Gerber accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 16 papers to Dr. Gerber, published from 2012 to 2023. 2021 was the busiest year, with 4. The most frequent topics are Practice Patterns, Physicians', Genitalia, Male and Laparoscopy. Dr. Gerber has published most often in Urology. Dr. Gerber's most frequent co-authors are Chester Jungdon Koh, MD, Paul F. Austin, MD and Kunj Raju Sheth, MD.

CMS Open Payments shows 6 general payments to Dr. Gerber from 5 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 100% of the total. Beutlich Pharmaceuticals LLC paid the most, $39.

Dr. Gerber graduated from McGovern Medical School in 2013.

Dr. Gerber is in network with 20 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.